Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinityenhanced NY-ESO-1-targeting TCR-redirected T cell transfer.
Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinityenhanced NY-ESO-1-targeting TCR-redirected T cell transfer.
复制标题
使用新型亲和力增强型 NY-ESO-1 靶向 TCR 重定向 T 细胞转移治疗滑膜肉瘤患者的肿瘤反应和早发细胞因子释放综合征。
DOI：
--
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Shiku H.
中科院分区：
文献类型：
--
作者：
Ishihara M;Kitano S;Hattori H;Miyahara Y;Kato H;Mishima H;Yamamoto N;Funakoshi T;Kojima T;Sasada T;Sato E;Okamoto S;Tomura D;Chono H;Nukaya I;Mineno J;Ikeda H;Watanabe T;Kageyama S;Shiku H.
